Lifecore Biomedical, Inc. Share Price & Technical Analysis
LFCR · $4.83 (-2.03%)
Healthcare / Drug Manufacturers - Specialty & Generic
$4.83
-2.03%
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device p…
Price chart
Seasonality
May has 1 positive and 4 negative years (last 5 years shown)
-4% return in May, 28% avg return in past 3 year May month.
-28% return in 2026, 35% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 7% | -17% | -49% | 34% | -4% | – | – | – | – | – | – | – | -28% |
| 25 | -20% | 0% | 19% | -3% | -1% | 19% | -14% | 10% | -1% | -1% | 10% | 5% | 22% |
| 24 | 5% | 29% | -36% | 19% | -9% | -12% | 21% | -30% | 14% | 16% | 28% | -1% | 43% |
| 23 | -6% | -8% | -34% | 11% | 95% | 18% | 9% | -24% | -5% | -7% | 4% | -14% | 40% |
| 22 | -4% | 7% | 0% | -15% | -4% | 4% | 5% | 1% | -14% | 11% | -14% | -24% | -45% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Downtrend · Neutral
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications. In addition, it offers product development services, including analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and materials production for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$165.04M
P/E ratio
—
52W high
$8.98
52W low
$3.63
Volume
63,463
Beta
1.08
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Lifecore Biomedical, Inc. share price today?
- Lifecore Biomedical, Inc. (LFCR) last traded around $4.83 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does LFCR have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for LFCR. Download the app for real-time alerts.
- How can I analyze Lifecore Biomedical, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.